Professional Pharmaceutical Consultants Recommend Pursuing Key Account Management Strategies

Some business practitioners use a metric termed the 80/20 rule, which dictates that 80% of an organisation's business comes from just 20% of its clients. This can be the subject of conjecture and certain clients are always seen as more important by the pharmaceutical company, due either to their pure volume of sales, their position in the market or other important considerations such as a transition to other market areas. In these cases, key account management strategies must be established by the company and must be adequately communicated and implemented within the sales and marketing team as a core priority.

A pharmaceutical company has many different stakeholders and must satisfy a number of different “clients.” The company is always involved in industry positioning, political lobbying, public relations and media, as well as the fundamental issues of sales, marketing and financial measurements. There is a lot to take on, from a daily and weekly perspective and company executives must ensure that they do not try and address too many complex issues while diluting their overall effectiveness. Key account management will not be effective if certain layers of communication are not maintained, leading to a less efficient sales and marketing operation and calling for a pharmaceutical consulting firm to be retained for best effect.

Once an account is designated as key to the success of the business, a determination should be made and a plan of action composed in concert with the pharmaceutical consultants. From the client perspective, what value do they gain from the relationship with the pharmaceutical company and vice versa? There should be an interactive approach to communication here and the goal should be to create a “win-win” scenario at all times, regardless of complexity. The key account is more likely to want to continue with the company if value is delivered over and above the core essentials.

A comfort zone must be the desired result, for if the client senses this, then a continuation can be expected and an expansion possible. Trust is everything and the establishment of a comfort zone promotes the client to relax many of the resources it may engage to control the associated activities, marking the relationship as efficient in its eyes.

Some experts observe that account management is really about damage control. Every now and again problems and issues will undoubtedly arise. It falls to the company to try and understand how a client works and to do its best to anticipate any problems or objections before they occur. The more educated the sales and marketing team and the better the training levels initiated, the more likely it is that any potential stumbling blocks will be easily resolved.

Key account management requires a constant review of the client's interpretation of the relationship. As always, a level of satisfaction is at the top of the list and when senior management goes overboard, a long-term relationship is likely, with great potential for additional revenues. In almost every instance, pharma consulting firms practice the art of delivering satisfaction.

Alan Gillies is the CEO of L2L Consulting, a cutting-edge pharma consultancy firm which specialises in optimising productivity and performance within international companies by applying tailored organisational strategies.